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Introduction
Continuous renal replacement therapy (CRRT) has 
become an established treatment for patients with acute 
kidney injury in the intensive care unit (ICU). Premature 
circuit clotting is a common problem, leading to reduced 
circuit life, to reduced clearance and also to increased 
blood loss, work load and cost of therapy [1]. Th  ere  are 
diﬀ  erent ways of maintaining the circuit patent [2]. An 
international questionnaire showed that in the UK more 
than 98% of ICUs surveyed used unfractionated heparin 
[3]. Th   e major advantages of unfractionated heparin are 
the low costs, familiarity, ease of administration and 
reversibility with protamine. CRRT is predominantly 
nurse-led [4]. After a decision is made to start CRRT, 
nurses usually prepare and manage the technique.
Unfractionated heparin is the ﬁ  rst-line anticoagulant in 
our unit. In order to enable the nursing staﬀ   to manage 
CRRT eﬀ   ectively and safely, we aimed to have clear 
guidelines in place, including an algorithm for the use of 
heparin.
Methods
We contacted seven large ICUs in the UK and three units 
outside the UK. None of the ICUs contacted had a 
guideline for the use of unfractionated heparin during 
CRRT. We therefore designed an algorithm based on data 
from the literature and our own clinical experience 
(Figure 1).
Results
Th   e principles of the algorithm (Figure 1) are as follows. 
First, unfractionated heparin is administered via the 
circuit. Second, heparin is administered into the circuit 
priming solution before the blood is in contact with 
plastic surfaces (10,000 iu heparin/1,000 ml of 0.9% 
NaCl). Th   ird, the dose of heparin is based on the patient’s 
body weight. Fourth, the starting dose of heparin is 
individualised depending on the risk of bleeding and the 
previous circuit life – subsequent doses can be adjusted 
by the nursing staﬀ   according to the algorithm without 
the need for a medical review. Fifth, there is no target 
activated partial thromboplastin time ratio but this ratio 
is kept ≤2 to prevent over-anticoagulation. Sixth, regular 
attention is paid to nonpharmacological methods to 
maintain circuit patency (that is, change of vascular 
access, blood ﬂ  ow, predilution/postdilution ratio).
A recent audit covering the period May 2008 to May 
2009 conﬁ  rmed a mean circuit life of 19.8 hours using 
unfractionated heparin without any untoward incidents.
Copies of our algorithm have already been requested 
by several ICUs in the UK. Th   e aim of the present paper 
is therefore to share our practice more widely.
Conclusion
Our heparin algorithm allows nurse-led eﬀ  ective and safe 
anticoagulation with unfractionated heparin during 
CRRT.
Abbreviations
CRRT, continuous renal replacement therapy; ICU, intensive care unit.
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Abstract
Premature circuit clotting is a problem during 
continuous renal replacement therapy. We describe 
an algorithm for individualised anticoagulation with 
unfractionated heparin based on the patient’s risk of 
bleeding and previous circuit life. The algorithm allows 
eff  ective and safe nurse-led anticoagulation during 
continuous renal replacement therapy.
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Figure 1. Algorithm for heparin anticoagulation during continuous renal replacement therapy. Algorithm is based on using 10,000 iu 
heparin in 40 ml of 0.9% NaCl. APC, activated protein C; APTTr, activated partial thromboplastin time ratio; CRRT, continuous renal replacement 
therapy; HIT, heparin-induced thrombocytopenia; INR, international normalised ratio; iv, intravenous; post-op, postoperative.
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